• Disease Team Leader, Melanoma, UH Case Medical Center
  • Assistant Professor, Medicine, CWRU School of Medicine

Request an Appointment

Refer a Patient

(216)844-3951

  • Gender: Male
  • Online Personal Health Record Available

Board Certifications

American Board of Internal Medicine - Medical Oncology

Education & Training

Undergraduate

1990, University of Mississippi

Medical / Professional School(s)

1994, University of Mississippi School of Medicine

Internship

1995, Internal Medicine - University of Mississippi Medical Center and School of Medicine

Residency

1997, Internal Medicine - University of Mississippi Medical Center and School of Medicine

Fellowship

2000, Hematology/Oncology - Beth Israel Deaconess Medical Center

Research Fellowship

2002, Hematology/Oncology - Beth Israel Deaconess Medical Center

Expertise

Bone and Soft Tissue Cancer (Sarcoma), Cutaneous Lymphomas, High-Dose Interleukin-2 (HD IL-2), Immunotherapy, Melanoma, Renal Cell Carcinoma

Office Locations

UH Case Medical Center
(216)844-3951
Department of Medicine-Hematology and Oncology
11100 Euclid Ave
Cleveland, OH 44106
Get Directions

UH Chagrin Highlands Health Center
(216)844-3951
3909 Orange Pl
Seidman Cancer Center, Ste 1100
Orange Village, OH 44122
Get Directions

UH Seidman Cancer Center
(216)844-3951
11100 Euclid Ave
Department of Medicine-Hematology and Oncology
Cleveland, OH 44106
Get Directions

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

For calendar year 2012, Henry Koon, MD disclosed the following Outside Relationships with Industry:


Bristol Myers Squibb - Consulting

Genentech, Inc. - Consulting

Merck & Co. Inc. - Consulting

Prometheus - Consulting